Clinical practice guidelines for the prevention and diagnosis of lung cancer
Please note these guidelines are currently under development and draft questions are being released for public consultation and published in a staged approach. For information on the current status of the guidelines reviews, please email guidelines (at) cancer.org.au.
Screening and early detection
- In people at risk of lung cancer, does population based screening with chest radiography reduce mortality?
Diagnosis and staging
- In people undergoing lung cancer evaluation, does concurrent diagnosis and staging provide greater benefit for patient outcomes compared to sequential testing for diagnosis followed by staging?
- For patients undergoing workup for known or suspected lung cancer, what is the optimal timing of PET/CT? Before or after tissue biopsy confirmation?
- Does routine follow-up improve patient outcomes in people who have curative intent treatments for lung cancer?
- What are the optimal follow-up tests for people with lung cancer who have had curative intent treatment?
- What is the optimal model (provider) of care for the follow up of people with lung cancer who have had curative intent treatment?
- Guideline development process
- List of clinical questions
- Working party members and contributors
- Conflict of interest register